Sign up to save your podcasts
Or
Share The Lollipop War Has Begun
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Lollipop War Has Begun
Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.
Get $50 off your first job post at www.LinkedIn.com/Fool.
View all episodes
By The Motley Fool
4.7
16041,604 ratings
Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.
Get $50 off your first job post at www.LinkedIn.com/Fool.
More shows like MarketFoolery
View all
WSJ Tech News Briefing
1,642 Listeners
Mad Money w/ Jim Cramer
4,080 Listeners
WSJ Your Money Briefing
1,715 Listeners
Investing Insights
496 Listeners
Motley Fool Money
3,177 Listeners
Industry Focus
826 Listeners
Money Tree Investing
658 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,364 Listeners
Motley Fool Answers
806 Listeners
Rule Breaker Investing
938 Listeners
The Investing for Beginners Podcast - Your Path to Financial Freedom
1,409 Listeners
Wall Street Breakfast
1,022 Listeners
The Best One Yet
9,595 Listeners
The Long View
880 Listeners
The Intrinsic Value Podcast - The Investor’s Podcast Network
558 Listeners
Squawk Pod
545 Listeners
Stock Market Today With IBD
43 Listeners